Presentation and outcomes of patients with multiple myeloma harboring gain or amplification of 1q21 and receiving novel agent therapies: results from a single-center study.
Sign Up to like & getrecommendations! Published in 2023 at "Hematology"
DOI: 10.1080/16078454.2023.2177979
Abstract: OBJECTIVE Gain or amplification 1q21 (1q21+) is one of the most common recurrent cytogenetic abnormalities in multiple myeloma (MM). Our aim was to explore the presentation and outcomes of patients with MM harboring 1q21 + . METHODS… read more here.
Keywords: gain amplification; patients 1q21; amplification 1q21; del 13q ... See more keywords
Acquired Chromosomal Abnormalities t(14;16), Del(17p) or Del(13q) after Receiving Chemotherapies Predict the Poor Prognosis of Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.3116.3116
Abstract: Introduction: Multiple myeloma (MM) is known as heterogeneous disease characterized by the clonal proliferation of tumor plasma cells. Recently, the prognosis of MM is classified depending on the appearance of cytogenetic abnormalities. However, no publication… read more here.
Keywords: del 17p; 17p del; prognosis; del 13q ... See more keywords